← All indications
Fistula
Abnormal communication most commonly seen between two internal organs, or between an internal organ and the surface of the body.
Subtype terms (8)
More specific conditions that are subtypes of Fistula in the MeSH hierarchy.
- Cutaneous Fistula
- Digestive System Fistula
1 drug approved
- Oral Fistula
- Perilymphatic Fistula
- Respiratory Tract Fistula
- Urinary Fistula
1 drug experimental
- Vaginal Fistula
1 drug experimental
- Vascular Fistula
Drugs by status
Phase 3 trials (1)
Phase 2 trials (6)
Phase 1 trials (3)
Organizations
Organization Involved with Phase 4 Indications (36)
- Takeda
- Millennium Pharmaceuticals
- California Institute of Renal Research, Inc.
- Harrow Health
- Shahid Beheshti University of Medical Sciences
- Baskent University
- Baylor University
- Children's Medical Center Dallas
- Harvard University
- Dartmouth University
- Emory University
- University of Washington
- Hospital de Viladecans
- Indiana University
- Mahidol University
- Northwestern University
- Oregon Health and Science University
- PVS Memorial Hospital
- Siriraj Hospital
- Stanford University
- University of Malaya
- University of New Mexico
- University of Bern
- University of Birmingham
- Yonsei University
- Columbia University
- University of Colorado, Denver
- University of Basel
- University of Texas at Houston
- University of Mississippi
- +6 more
Organization Involved with Phase 3 Indications (38)
- Sanofi
- Ipsen
- Novartis
- Anterogen Co., Ltd.
- Cellerix
- Ocera Therapeutics
- Proteon Therapeutics
- Vascular Therapies, Inc.
- TiGenix
- Foundation for Liver Research
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Boston University
- CAMC Health System
- Cornell University
- Duke University
- Hoosier Cancer Research Network
- Seoul National University
- Tufts University
- Universidad Autonoma de Madrid
- University of Exeter
- University of Iowa
- St. Louis University
- University of Ulsan
- Vanderbilt University
- Hebrew University
- Sun Yat-Sen University
- University of Massachusetts
- University of Alabama, Birmingham
- University of Paris
- +8 more
Organization Involved with Phase 2 Indications (29)
- Facet Biotech
- Shire
- AstraZeneca
- Merck
- PDL BioPharma
- Cell Therapy Catapult
- Cyathus Exquirere Pharmaforschungsgmbh
- Dialysis Clinic, Inc.
- Hadassah Medical Organization
- Albany Medical College
- University of London
- Englewood Hospital and Medical Center
- Medical Center Haaglanden
- National Cheng Kung University
- National University of Malaysia
- Reinier de Graaf Groep
- University of Virginia
- Southeast Renal Research Institute
- Leiden University
- University of Amsterdam
- Daehang Hospital
- Aix-University of Marseille
- HagaZiekenhuis
- Spaarne Gasthuis
- Alrijne Hospital
- Tergooi Ziekenhuis
- Spectranetics Corporation
- Papworth Hospital
- Videregen Therapeutics
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (17)
- Changi General Hospital
- Mansoura University
- Melbourne Health
- Nanjing University
- Sir Ganga Ram Hospital
- Trakya University
- University of Southern Denmark
- University of Toronto
- University of Vermont
- Chongqing Medical University
- University of Ankara
- Badalona Hospital Germans Trias i Pujol
- University of Lyon
- Ruhr University Bochum
- American Society of Colon and Rectal Surgeons
- Assistance Publique - Hôpitaux de Paris
- Yuksek Ihtisas University